ماهي افضل طريقه علاجية ابدا بها لعلاج بهاق نشط

The most appropriate initial treatment approach for actively progressing vitiligo is the use of short-term potent or very potent topical corticosteroids. These should be applied to the affected areas to help reduce inflammation and inhibit the immune-mediated destruction of melanocytes, which is characteristic of vitiligo NICE CKS.

Alternatively, topical calcineurin inhibitors may be offered especially when corticosteroids are unsuitable, for example on facial or sensitive skin areas, as they provide immune modulation without the side effects associated with corticosteroids NICE CKS.

Management should also include advising on sun protection to prevent UV-induced damage to the depigmented skin patches and considering referral to a skin camouflage service if appropriate NICE CKS.

Regular clinical review is important to assess treatment response and monitor adverse effects NICE CKS.

The rationale for corticosteroid and calcineurin inhibitor use as first-line treatment is supported by the autoimmune pathogenesis of vitiligo, where immune activation—particularly of CD8+ T cells triggered by innate immune mechanisms—leads to melanocyte destruction Wang et al. 2025Marrapodi et al. 2025. Early immunomodulation can help to control this autoimmune activity.

While phototherapy and more advanced systemic or targeted therapies are options for more extensive or refractory disease, initial treatment in primary care or at early stages is topical corticosteroids or calcineurin inhibitors NICE CKS. Emerging literature highlights novel immunological targets and therapies but these are not yet part of routine first-line management Xie et al. 2023Wang et al. 2025.